ClinicalTrials.Veeva

Menu

The Effect of Prescription Medications in Marijuana Users

Johns Hopkins University logo

Johns Hopkins University

Status and phase

Completed
Phase 2
Phase 1

Conditions

Marijuana Abuse

Treatments

Drug: Dronabinol 60mg/day
Drug: Dronabinol 30mg/day
Drug: Dronabinol 120mg/day
Drug: Placebo

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00893074
NA_00026278
R01DA025044 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

A subset of heavy marijuana users have trouble quitting marijuana use and the number of those seeking treatment for problems related to marijuana is increasing. The purpose of this research study is to investigate whether dronabinol can reduce withdrawal effects associated with stopping marijuana use, if dronabinol can reduce the rewarding effects of smoked marijuana, and whether there are any cognitive performance deficits associated with dronabinol doses that produce such effects.

Enrollment

24 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • current use of marijuana
  • able to give informed consent

Exclusion criteria

  • dependence on drug other than marijuana
  • pregnant, breast feeding, or planning to become pregnant within the next 3 months
  • currently seeking treatment for cannabis-related problems or otherwise trying to reduce use
  • use of cannabis under the guidance of a physician for a medical disorder
  • unstable or uncontrolled cardiovascular disease (e.g., hypertension, angina)
  • allergy to study medication

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

24 participants in 1 patient group

0, 30, 60, and 120mg dronabinol
Other group
Description:
0, 30, 60, and 120mf dronabinol was administered in a randomized within-subjects crossover study to compare the medication dose effects of cannabis withdrawal, cognitive performance, and response to acute cannabis dosing
Treatment:
Drug: Dronabinol 120mg/day
Drug: Placebo
Drug: Dronabinol 30mg/day
Drug: Dronabinol 60mg/day

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems